Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artificial Intelligence
MedTech
Roche shells out up to $1B for PathAI to boost AI diagnostics
Roche will pay more than $1 billion to acquire digital pathology specialist Path AI in a move to bolster its use of artificial intelligence.
Joseph Keenan
May 7, 2026 9:30am
From R&D to M&A: Big Pharmas showcase ‘measurable impact’ of AI
May 7, 2026 9:10am
Recursion's new CEO is bringing the AI outfit back to earth
May 6, 2026 6:30am
Fierce Pharma
Sanofi invests $294M to scale Toronto AI hub
May 5, 2026 9:21am
FDA unveils plan for real-time review of clinical trial data
Apr 28, 2026 1:52pm
WCG acquires The Contract Network to streamline clinical trials
Apr 24, 2026 1:38pm